BioCentury
ARTICLE | Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica computational chemistry/biology news

June 11, 2012 7:00 AM UTC

The U.K.'s Technology Strategy Board granted the companies £1 million ($1.5 million) to develop a highly-scalable discovery platform to identify diverse small molecules against therapeutic targets usi...